Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Drospirenone-Containing Contraceptives on Blood Pressure
NCT02342093Phase 4Completed
- Sponsor
- Universidade de São Paulo
- Start
- Jan 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ethinyl estradiol and drospirenone in contraception (2 arms), sponsored by Universidade de São Paulo. Primary endpoint: Ambulatory Blood Pressure at 6 months. Started Jan 2011; status: completed.
02
Drugs
ethinyl estradioldrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on NCT02342093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02342093.